Medicrea received FDA 510(k) clearances for its PASS® XS posterior fixation and LigaPASS® XS band connector components, designed to address spinal deformities in small stature patients.
Strategic transactions year to date in 2016 represent participants from OEMs, Suppliers, Distributors and Private Equity, with values ranging from $10 million to $1 billion.
Data collection is paramount to the success of any orthopaedic device. What happens to the much-coveted postmarket data/initiative during and after a merger or acquisition? We posed this question to Vicki Anastasi, Vice President & Global Head, Medical Devices & Diagnostics Research with ICON plc.
Paradigm BioDevices completed its 25,000th case with the QuickDraw MIS Bone Harvester™. A single-use, sterile version of the system is slated for launch next week, and CE Mark approval is expected by year-end.